Precision Therapeutics Reports Fiscal Year 2017 Financial Results

Company reports strengthening STREAMWAY® System sales and new strategic focus on the emerging precision medicine market MINNEAPOLIS, April 02, 2018 (GLOBE NEWSWIRE)  Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results for the three and twelve months ended December 31, 2017 and provides a business update on its plans to transition its strategic focus to precision medicine and the Contract Research Organization The post Precision Therapeutics Reports Fiscal Year 2017 Financial Results appeared first on Public Wire.
http://bit.ly/2H7ClJ5